Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Heron Therapeutics (HRTX) over the last 10 years, with Sep 2025 value amounting to 0.01%.

  • Heron Therapeutics' Return on Capital Employed rose 20.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.08% for FY2024, which is 62.00% up from last year.
  • Heron Therapeutics' Return on Capital Employed amounted to 0.01% in Q3 2025, which was up 121.21% from -0.05% recorded in Q2 2025.
  • Over the past 5 years, Heron Therapeutics' Return on Capital Employed peaked at 0.01% during Q3 2025, and registered a low of -1.46% during Q2 2022.
  • Over the past 3 years, Heron Therapeutics' median Return on Capital Employed value was -0.34% (recorded in 2024), while the average stood at -0.45%.
  • In the last 5 years, Heron Therapeutics' Return on Capital Employed crashed by 61bps in 2022 and then spiked by 77bps in 2024.
  • Over the past 5 years, Heron Therapeutics' Return on Capital Employed (Quarterly) stood at -0.84% in 2021, then fell by 13bps to -0.98% in 2022, then grew by 22bps to -0.76% in 2023, then skyrocketed by 67bps to -0.09% in 2024, then climbed by 20bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, -0.05% for Q2 2025, and -0.02% during Q1 2025.